James Investment Research’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,155	Closed	-$18K	–	530
2019 Q3	$18K	Hold	1,155	–	–	﹤0.01%	477
2019 Q2	$23K	Buy	1,155 +510	+79%	+$10.2K	﹤0.01%	555
2019 Q1	$11K	Buy	+645	New	+$11K	﹤0.01%	727